Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
4.2 EUR | +0.96% | -20.15% | -49.70% |
Apr. 29 | Biosynex: agreement for ProciseDx in North America | CF |
2023 | Biosynex: merger with Theradiag completed | CF |
Sales 2021 | 383M 408M | Sales 2022 | 197M 210M | Capitalization | 141M 150M |
---|---|---|---|---|---|
Net income 2021 | 104M 111M | Net income 2022 | 15M 15.99M | EV / Sales 2021 | 0.5 x |
Net cash position 2021 | 96.72M 103M | Net cash position 2022 | 35.09M 37.41M | EV / Sales 2022 | 0.54 x |
P/E ratio 2021 |
2.63
x | P/E ratio 2022 |
9.08
x | Employees | 551 |
Yield 2021 |
7.6% | Yield 2022 |
-
| Free-Float | 39.43% |
1 day | +0.96% | ||
1 week | -20.15% | ||
Current month | -12.77% | ||
1 month | -12.77% | ||
3 months | -46.70% | ||
6 months | -50.59% | ||
Current year | -49.70% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Lamy
FOU | Founder | - | 05-03-14 |
Larry Abensur
CEO | Chief Executive Officer | 69 | 05-03-14 |
Thierry Paper
FOU | Founder | 60 | 05-03-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Thierry Paper
FOU | Founder | 60 | 05-03-14 |
Thomas Lamy
FOU | Founder | - | 05-03-14 |
Larry Abensur
CEO | Chief Executive Officer | 69 | 05-03-14 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 4.2 | +0.96% | 5,876 |
24-04-29 | 4.16 | +1.71% | 8,711 |
24-04-26 | 4.09 | -0.73% | 9,119 |
24-04-25 | 4.12 | -23.13% | 69,990 |
24-04-24 | 5.36 | +1.13% | 5,754 |
Real-time Euronext Paris, April 30, 2024 at 11:35 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-49.70% | 48.33M | |
-0.60% | 12.63B | |
-9.59% | 7.67B | |
+1.82% | 5.42B | |
+0.02% | 4.57B | |
+7.32% | 4.56B | |
-47.68% | 3.51B | |
+6.42% | 2.59B | |
-14.59% | 2.05B | |
+2.25% | 1.77B |
- Stock Market
- Equities
- ALBIO Stock